Adial Pharmaceuticals
ADIL
10 hedge funds and large institutions have $917K invested in Adial Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
11% more funds holding
Funds holding: 9 → 10 (+1)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
10% less capital invested
Capital invested by funds: $1.02M → $917K (-$107K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$18.1K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$6.38K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$2.13K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18.1K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $424K | -$18.1K | -17 | -4% |
|
2
BlackRock
New York
| $311K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $116K | – | – | – |
|
4
Brown Advisory
Baltimore,
Maryland
| $39K | – | – | – |
|
|
5
Commonwealth Equity Services
Waltham,
Massachusetts
| $16K | +$18.1K | +17 | New |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $6K | +$6.38K | +6 | +600% |
|
|
7
Victory Capital Management
San Antonio,
Texas
| $2K | +$2.13K | +2 | New |
|
8
Morgan Stanley
New York
| $1K | – | – | – |
|
9
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| $1K | +$1.06K | +1 | New |
|
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$3K | -3 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$3K | -3 | Closed |
|
ADIL Hedge Fund Activity: Q3 2019 in Review
10 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q3 2019, worth a combined $917K — down 10% from $1.02M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ADIL positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $18.1K. The largest seller was Vanguard Group, cutting an estimated $18.1K.
- 10 institutional investors held Adial Pharmaceuticals (ADIL) as of Q3 2019, up from 9 in Q2 2019.
- Funds reported $917K of Adial Pharmaceuticals stock for Q3 2019, down 10% quarter-over-quarter.
- 3 funds opened new Adial Pharmaceuticals positions in Q3 2019 and 2 closed out, a net change of +1 holder.
- The largest Adial Pharmaceuticals buyer in Q3 2019 was Commonwealth Equity Services, an estimated $18.1K added.
- The largest Adial Pharmaceuticals seller in Q3 2019 was Vanguard Group, an estimated $18.1K sold.
Based on aggregated 13F filings for Q3 2019.